Ligand exchange of major histocompatibility complex class II proteins is triggered by H-bond donor groups of small molecules

被引:39
作者
Falk, K
Lau, JM
Santambrogio, L
Esteban, VM
Puentes, F
Rötzschke, O
Strominger, JL [1 ]
机构
[1] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA
[2] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany
[3] Dana Farber Canc Inst, Dept Canc Immunol AIDS, Boston, MA 02115 USA
关键词
D O I
10.1074/jbc.M109098200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hydrogen bonds (H-bonds) are crucial for the stability of the peptide-major histocompatibility complex (MHC) complex. In particular, the H-bonds formed between the peptide ligand and the MHC class 11 binding site appear to have a great influence on the half-life of the complex. Here we show that functional groups with the capacity to disrupt hydrogen bonds (e.g. -OH) can efficiently catalyze ligand exchange reactions on HLA-DR molecules. In conjunction with simple carrier molecules (such as propyl or benzyl residues), they trigger the release of low affinity ligands, which permits the rapid binding of peptides with higher affinity. Similar to HLA-DM, these compounds are able to influence the MHC class 11 ligand repertoire. In contrast to HLA-DM, however, these simple small molecules are still active at neutral pH. Under physiological conditions, they increase the number of "peptide-receptive" MHC class 11 molecules and facilitate exogenous peptide loading of dendritic cells. The drastic acceleration of the ligand exchange on these antigen presenting cells suggests that, in general, availability of H-bond donors in the extracellular milieu controls the rate of MHC class II ligand exchange reactions on the cell surface. These molecules may therefore be extremely useful for the loading of antigens onto dendritic cells for therapeutic purposes.
引用
收藏
页码:2709 / 2715
页数:7
相关论文
共 45 条
[1]   Functional HLA-DM on the surface of B cells and immature dendritic cells [J].
Arndt, SO ;
Vogt, AB ;
Markovic-Plese, S ;
Martin, R ;
Moldenhauer, G ;
Wölpl, A ;
Sun, YS ;
Schadendorf, D ;
Hämmerling, GJ ;
Kropshofer, H .
EMBO JOURNAL, 2000, 19 (06) :1241-1251
[2]   IN-VIVO AND IN-VITRO FORMATION AND DISSOCIATION OF HLA-DR COMPLEXES WITH INVARIANT CHAIN-DERIVED PEPTIDES [J].
AVVA, RR ;
CRESSWELL, P .
IMMUNITY, 1994, 1 (09) :763-774
[3]   Alteration of a single hydrogen bond between class II molecules and peptide results in rapid degradation of class II molecules after invariant chain removal [J].
Ceman, S ;
Wu, SH ;
Jardetzky, TS ;
Sant, AJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (11) :2139-2149
[4]   PREDOMINANT NATURALLY PROCESSED PEPTIDES BOUND TO HLA-DR1 ARE DERIVED FROM MHC-RELATED MOLECULES AND ARE HETEROGENEOUS IN SIZE [J].
CHICZ, RM ;
URBAN, RG ;
LANE, WS ;
GORGA, JC ;
STERN, LJ ;
VIGNALI, DAA ;
STROMINGER, JL .
NATURE, 1992, 358 (6389) :764-768
[5]   HLA-DM recognizes the flexible conformation of major histocompatibility complex class II [J].
Chou, CL ;
Sadegh-Nasseri, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (12) :1697-1706
[6]  
Coligan JE, 1992, CURRENT PROTOCOLS IM
[7]   Effects of ethanol on ion channels [J].
Crews, Fulton T. ;
Morrow, A. Leslie ;
Criswell, Hugh ;
Breese, George .
INTERNATIONAL REVIEW OF NEUROBIOLOGY, VOL 39, 1996, 39 :283-367
[8]   HLA-DM interactions with intermediates in HLA-DR maturation and a role for HLA-DM in stabilizing empty HLA-DR molecules [J].
Denzin, LK ;
Hammond, C ;
Cresswell, P .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (06) :2153-2165
[9]   Induction and suppression of an autoimmune disease by oligomerized T cell epitopes:: Enhanced in vivo potency of encephalitogenic peptides [J].
Falk, K ;
Rötzschke, O ;
Santambrogio, L ;
Dorf, ME ;
Brosnan, C ;
Strominger, JL .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (04) :717-730
[10]   Dendritic cells in cancer immunotherapy [J].
Fong, L ;
Engleman, EG .
ANNUAL REVIEW OF IMMUNOLOGY, 2000, 18 :245-273